ITI Securities Broking Ltd

Change Company Name

Cipla Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 500087	ISIN Demat INE059A01026	Book Value 423.36	NSE Symbol CIPLA	Div & Yield % 0.93	Market Cap (₹ Cr.) 113,423.33	P/E 34.59	EPS 40.59	Face Value 2

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
INCOME :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Sales Turnover	20,065.04	19,952.49	17,482.98	15,058.31	15,380.82	11,302.71
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	20,065.04	19,952.49	17,482.98	15,058.31	15,380.82	11,302.71
Other Income	1,122.65	1,279.38	1,433.72	826.20	742.05	653.91
Stock Adjustments	596.45	229.87	-104.57	-194.32	541.93	-6.41
Total Income	21,784.14	21,461.74	18,812.13	15,690.19	16,664.80	11,950.21
EXPENDITURE :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Raw Materials	6,580.31	5,699.59	4,977.62	4,739.89	6,467.54	4,097.20
Power & Fuel Cost	299.43	290.24	271.66	257.07	247.58	234.58
Employee Cost	3,350.48	3,054.87	2,688.51	2,380.68	2,122.02	1,703.58
Other Manufacturing Expenses	1,548.61	1,374.94	997.59	710.80	919.08	906.09
Selling & Administrative Expenses	3,799.01	3,493.86	3,419.17	3,047.94	2,107.17	1,578.59
Miscellaneous Expenses	892.63	490.42	539.71	560.62	348.13	-291.15
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	16,470.47	14,403.92	12,894.26	11,697.00	12,211.52	8,228.89
Operating Profit	5,313.67	7,057.82	5,917.87	3,993.19	4,453.28	3,721.32
Interest	19.30	15.11	20.25	22.27	26.93	45.07
Gross Profit	5,294.37	7,042.71	5,897.62	3,970.92	4,426.35	3,676.25
Depreciation	658.43	573.89	587.59	595.91	546.62	468.62
Profit Before Tax	4,635.94	6,468.82	5,310.03	3,375.01	3,879.73	3,207.63
Tax	1,101.90	1,360.32	1,226.69	901.63	949.49	756.27
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	18.86	-49.15	6.09	-40.09	-27.69	-16.92
Reported Net Profit	3,515.18	5,157.65	4,077.25	2,513.47	2,957.93	2,468.28
Extraordinary Items	72.74	344.27	39.14	-41.59	48.88	39.09
Adjusted Net Profit	3,442.44	4,813.38	4,038.11	2,555.06	2,909.05	2,429.19
Adjustment below Net Profit	-13.52	-12.96	-74.47	-10.52	18.48	13.71
P & L Balance brought forward	27,045.69	22,950.83	19,634.22	17,534.77	14,961.71	12,479.72
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1,292.40	1,049.83	686.17	403.50	403.35	0.00
P & L Balance carried down	29,254.95	27,045.69	22,950.83	19,634.22	17,534.77	14,961.71
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	650.00	800.00	650.00	425.00	250.00	250.00
Dividend Per Share(Rs)	13.00	16.00	13.00	8.50	5.00	5.00
Earnings Per Share-Unit Curr	43.52	63.86	50.50	31.14	36.66	30.61
Earnings Per Share(Adj)-Unit Curr	43.52	63.86	50.50	31.14	36.66	30.61
Book Value-Unit Curr	423.39	397.46	346.49	305.25	279.05	247.10
Book Value(Adj)-Unit Curr	423.39	397.46	346.49	305.25	279.05	247.10

Profit & Loss

Market

News

Research

TECHNICAL

FUNDAMENTAL

Products

Attention Investors